Iniciar sesión para ver los precios por organización y contrato.
Seleccione un Tamaño
Cambiar Vistas
Acerca de este artículo
Fórmula lineal:
C2H5OH
Número CAS:
Peso molecular:
46.07
UNSPSC Code:
15101802
PubChem Substance ID:
NACRES:
NA.21
Beilstein/REAXYS Number:
1718733
MDL number:
Servicio técnico
¿Necesita ayuda? Nuestro equipo de científicos experimentados está aquí para ayudarle.
Permítanos ayudarleNombre del producto
Ethanol solution, suitable for fixing solution (blood films)
Quality Level
form
liquid, solution
greener alternative product characteristics
Safer Solvents and Auxiliaries
Learn more about the Principles of Green Chemistry.
sustainability
Greener Alternative Product
suitability
suitable for fixing solution (blood films)
format
mixture
greener alternative category
SMILES string
CCO
InChI
1S/C2H6O/c1-2-3/h3H,2H2,1H3
InChI key
LFQSCWFLJHTTHZ-UHFFFAOYSA-N
General description
Ethanol Fixative 80% is a solution of 80% v/v ethanol in water. It is used as a preservative for biological specimens in the fluid.
Application
Used as a fixative for blood films in Sigma Procedure 285 for Fetal Hemoglobin
Features and Benefits
We are committed to bringing you Greener Alternative Products, which adhere to one or more of The 12 Principles of Greener Chemistry. Ethanol is environmentally preferable green solvent and thus it aligns with "Safer Solvents and Auxiliaries". Click here for more information.
Still not finding the right product?
Explore all of our products under Ethanol solution
signalword
Danger
hcodes
Hazard Classifications
Eye Irrit. 2 - Flam. Liq. 2
Clase de almacenamiento
3 - Flammable liquids
wgk
WGK 1
flash_point_f
67.1 °F - closed cup
flash_point_c
19.5 °C - closed cup
Elija entre una de las versiones más recientes:
¿Ya tiene este producto?
Encuentre la documentación para los productos que ha comprado recientemente en la Biblioteca de documentos.
Ross B Mounsey et al.
Experimental neurology, 273, 36-44 (2015-08-06)
Parkinson's disease (PD) is a common chronic neurodegenerative disorder, usually of idiopathic origin. Symptoms including tremor, bradykinesia, rigidity and postural instability are caused by the progressive loss of dopaminergic neurons in the nigrostriatal region of the brain. Symptomatic therapies are
Cem Kuscu et al.
Nature biotechnology, 32(7), 677-683 (2014-05-20)
RNA-guided genome editing with the CRISPR-Cas9 system has great potential for basic and clinical research, but the determinants of targeting specificity and the extent of off-target cleavage remain insufficiently understood. Using chromatin immunoprecipitation and high-throughput sequencing (ChIP-seq), we mapped genome-wide
Stefan Wieland et al.
Hepatology (Baltimore, Md.), 59(6), 2121-2130 (2013-10-15)
Approximately 50% of patients with chronic hepatitis C (CHC) have ongoing expression of interferon stimulated genes (ISGs) in the liver. It is unclear why this endogenous antiviral response is inefficient in eradicating the infection. Several viral escape strategies have been

